NASDAQ: RLMD - Relmada Therapeutics, Inc.

Yield per half year: -89.78%
Dividend yield: 0.00%
Sector: Healthcare

Current price
0.3981 $
Average price
0 $ -100%

Price based on EPS
2.08 $ +421.35%
0/10
8.00008.00006.00006.00004.00004.00002.00002.00000.00000.0000Mar '24Mar '24Apr '24Apr '24May '24May '24Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 2.08 $
Current price = 0.3981 $ (difference = +421.35%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 3.79 $
Current price = 0.3981 $ (difference = +852.41%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -48.8 $
Current price = 0.3981 $ (difference = -12 358.87%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription